Mingshan Niu (Niu Mingshan)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Top Venues

Journal of translational medicine

Journal of molecular medicine (Berlin, Germany)

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Yao Yao, Mei Yuan, Min Shi, Wenyu Li, Yuqian Sha, Yan Zhang, Canli Yuan, Jianping Luo, Zhenyu Li, Chengcheng Liao, Kailin Xu, Mingshan Niu
Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death. Blood advances 8 (15) (2024)
Yao Yao, Mei Yuan, Min Shi, Wenyu Li, Yuqian Sha, Yan Zhang, Canli Yuan, Jianping Luo, Zhenyu Li, Chengcheng Liao, Kailin Xu, Mingshan Niu
Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death. Blood advances 8 (15) (2024)
Yao Yao, Mei Yuan, Min Shi, Wenyu Li, Yuqian Sha, Yan Zhang, Canli Yuan, Jianping Luo, Zhenyu Li, Chengcheng Liao, Kailin Xu, Mingshan Niu
Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death. Blood advances 8 (15) (2024)
Yao Yao, Mei Yuan, Min Shi, Wenyu Li, Yuqian Sha, Yan Zhang, Canli Yuan, Jianping Luo, Zhenyu Li, Chengcheng Liao, Kailin Xu, Mingshan Niu
Halting Multiple Myeloma with MALT1 Inhibition: Suppressing BCMA-Induced NF-κB and Inducing Immunogenic Cell Death. Blood advances (2024)
Yajie Liu, Kairan Yu, Xiaotian Kong, Keren Zhang, Lingyan Wang, Nana Zhang, Qiushi Chen, Mingshan Niu, Wen-Li Li, Xiaomin Zhong, Sijin Wu, Jianing Zhang, Yubo Liu
FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer. Science advances 9 (33) (2023)
Ninghan Zhang, Jiawen Xu, Rong Wang, Ting Pan, Huanxin Zhang, Lingling Yin, Yao Yao, Linyan Xu, Shengyun Zhu, Qingyun Wu, Zhenyu Li, Xuejiao Liu, Kailin Xu, Mingshan Niu
CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia. Journal of molecular medicine (Berlin, Germany) 99 (10) (2021)
Wenjie Shi, Jialei Qi, Xiang Gao, Ninghan Zhang, Huihui Zhang, Rong Wang, Linyan Xu, Yao Yao, Mingshan Niu, Kailin Xu
High expression of miR-338 is associated with poor prognosis in acute myeloid leukemia undergoing chemotherapy. Journal of cellular physiology 234 (11) (2019)
Huihui Zhang, Ninghan Zhang, Rong Wang, Tingting Shao, Yuan Feng, Yao Yao, Qingyun Wu, Shengyun Zhu, Jiang Cao, Huanxin Zhang, Zhenyu Li, Xuejiao Liu, Mingshan Niu, Kailin Xu
High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia. Journal of translational medicine 17 (1) (2019)
Chen Yang, Tingting Shao, Huihui Zhang, Ninghan Zhang, Xiaoying Shi, Xuejiao Liu, Yao Yao, Linyan Xu, Shengyun Zhu, Jiang Cao, Hai Cheng, Zhiling Yan, Zhenyu Li, Mingshan Niu, Kailin Xu
MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. Journal of translational medicine 16 (1) (2018)
Jiang Cao, Gang Wang, Hai Cheng, Chen Wei, Kunming Qi, Wei Sang, Li Zhenyu, Ming Shi, Huizhong Li, Jianlin Qiao, Bin Pan, Jing Zhao, Qingyun Wu, Lingyu Zeng, Mingshan Niu, Guangjun Jing, Junnian Zheng, Kailin Xu
Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia. American journal of hematology 93 (7) (2018)